COMMUNIQUÉS West-GlobeNewswire

LB Pharmaceuticals Reports Inducement Grants to New Employee Under Nasdaq Listing Rule 5635(c)(4)
09/10/2026
NEW YORK, Oct. 09, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that [...]
Integra Announces Pricing of Senior Secured Notes
09/10/2026
PRINCETON, N.J., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) (the “Company”) today announced the pricing of $450,000,000 aggregate principal amount of 9.500% senior secured [...]
EssilorLuxottica: Third-Quarter 2026 Revenue Conference Call Invitation
09/10/2026
Third-Quarter 2026 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our Third-Quarter 2026 Revenue [...]
EssilorLuxottica: Third-Quarter 2026 Revenue Conference Call Invitation
09/10/2026
Third-Quarter 2026 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our Third-Quarter 2026 Revenue [...]
AB Science annonce aujourd’hui ses résultats financiers semestriels au 30 juin 2026 et présente un point sur ses activités
09/10/2026
COMMUNIQU É DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS AU PREMIER SEMESTRE 2026 ET LES ÉVÉNEMENTS CLEFS DE LA PÉRIODE Évolution de la gouvernance d’AB Science et mise en place d’une nouvelle stratégie [...]
AB Science today reports its revenues for the first half of 2026 and provides an update on its activities
09/10/2026
PRESS RELEASE AB SCIENCE REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026 AND KEY EVENTS OF THE PERIOD Change in AB Science's governance and implementation of a new strategy Appointment of Stéphane Ledermann as [...]
Metro ENT Joins National Breathe Free Network, Beginning Its Next Chapter of ENT Care in the Dallas Area
09/10/2026
Partnership builds on Metro ENT’s established physician leadership while adding the resources and infrastructure of the National Breathe Free network. MESQUITE, Texas, Oct. 09, 2026 (GLOBE NEWSWIRE) -- National Breathe [...]
HCW Biologics Maintains Momentum Toward Completion of IND Application for Clinical Study to Evaluate Lead T-Cell Engager in Solid Tumors
09/10/2026
Communication with FDA at recent Type B meeting provided clear guidance for next steps to prepare IND application to support first-in-human clinical study in cancer HCW11-018b is Company’s lead candidate in its second- [...]
SkinHealth Systems Announces Reverse Stock Split
09/10/2026
Shares expected to begin trading on split-adjusted basis on October 14, 2026 LONG BEACH, Calif., Oct. 09, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems (Nasdaq: SKIN) (the “Company”), home to flagship brand Hydrafacial™, [...]
How to Tell Whether an E-commerce Brand Has Outgrown Its In-House Customer Support
09/10/2026
Transcom's Retail Peak Resilience Index finds cost per order can triple while order volume doubles in operating models tuned to an average week Promotion backlogs, coverage gaps and routine contacts crowding out [...]
Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia
09/10/2026
WELTRUZA ™ (olanzapine) for extended-release injectable suspension is the first and only once-monthly subcutaneous long-acting injectable (LAI) formulation of olanzapine for the treatment of schizophrenia in adults with [...]
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/10/2026
BEDFORD, Mass., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today [...]
Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical Dermatology Conference
09/10/2026
Denifanstat showed continued improvement and sustained efficacy across all efficacy endpoints through 52 weeks, including 57% IGA success, 72% reduction in total lesions, and 77% reduction in inflammatory lesions, and [...]
Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference
09/10/2026
MELBOURNE, Australia and SAN FRANCISCO, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying [...]
Trillium Dental’s Dr. Mark Northcott Reveals Which Halloween Treats Damage Kids’ Teeth and Which Are Surprisingly Safe
09/10/2026
OTTAWA, Ontario, Oct. 09, 2026 (GLOBE NEWSWIRE) -- With Halloween approaching, Dr. Mark Northcott, co-founder of Trillium Dental and a Doctor of Dental Surgery from McGill University and Yale University, is advising [...]
Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
09/10/2026
Collaboration will educate physicians and prostate cancer centers on the complementary roles of Telix’s PSMA-PET molecular imaging technologies and Profound’s MRI-guided TULSA-PRO ® Agreement provides Profound with [...]
Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial
09/10/2026
Dutch Cardiovascular Investigator Network (WCN) Leads European Enrollment in Phase 3 Study Evaluating Etripamil Nasal Spray for AFib-RVR MONTREAL and CHARLOTTE, N.C., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Milestone ® [...]
Nuvectis Pharma to Participate in the Maxim Growth Summit 2026
09/10/2026
Fort Lee, NJ, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the [...]
Nextech Unveils Agentic AI Capabilities for Patient Experience through Partnerships with Assort Health and EliseAI
09/10/2026
Specialty practices gain a choice of two leading AI patient access platforms, unveiled at AAO 2026 in New Orleans TAMPA, Fla., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Nextech , a leading technology partner for specialty [...]

Pages